These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24229459)

  • 1. The potential role of ‘non-rheumatic’ therapies in rheumatic disease.
    Massarotti EM; Solomon DH
    Arthritis Res Ther; 2013; 15(6):124. PubMed ID: 24229459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.
    Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Solus J; Tanner S; Stein CM
    Arthritis Res Ther; 2013; 15(5):R110. PubMed ID: 24020899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.
    Marder W; Khalatbari S; Myles JD; Hench R; Lustig S; Yalavarthi S; Parameswaran A; Brook RD; Kaplan MJ
    J Am Heart Assoc; 2013 Nov; 2(6):e000441. PubMed ID: 24252844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.
    Crowson CS; Rahman MU; Matteson EL
    J Rheumatol; 2009 Aug; 36(8):1606-10. PubMed ID: 19531760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis: Testing the inflammation-insulin resistance link in clinical trials.
    Sattar N; Kitas GD
    Nat Rev Rheumatol; 2013 Dec; 9(12):702-3. PubMed ID: 24247367
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.
    Kemp DE; Schinagle M; Gao K; Conroy C; Ganocy SJ; Ismail-Beigi F; Calabrese JR
    CNS Drugs; 2014 Jun; 28(6):571-81. PubMed ID: 24715548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular risk.
    Derosa G; Maffioli P
    Curr Mol Pharmacol; 2012 Jun; 5(2):272-81. PubMed ID: 22122457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months.
    Bae SC; Cho SK; Won S; Lee HS; Lee SH; Kang YM; Lee SH; Lee YA; Choe JY; Chung WT; Suh CH; Shim SC; Lee J; Yoon BY; Kim DW; Lee SS; Yoo WH; Kim JS; Jung YO; Nah SS; Lee CK; Song GG; Choi SJ; Joung CI; Koh H; Kim YJ
    Int J Rheum Dis; 2018 May; 21(5):1001-1009. PubMed ID: 29878615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study.
    Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
    Int J Rheum Dis; 2018 Nov; 21(11):1977-1985. PubMed ID: 27452347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin Resistance Intervention After Stroke Trial of Pioglitazone: Is This Perhaps the End of the Beginning?
    Ntaios G; Kent TA
    Stroke; 2016 Jul; 47(7):1962-4. PubMed ID: 27222525
    [No Abstract]   [Full Text] [Related]  

  • 12. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.
    Yarasheski KE; Cade WT; Overton ET; Mondy KE; Hubert S; Laciny E; Bopp C; Lassa-Claxton S; Reeds DN
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E243-51. PubMed ID: 20959530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
    Consoli A; Formoso G
    Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of melatonin supplementation on disease activity, oxidative stress, inflammatory, and metabolic parameters in patients with rheumatoid arthritis: a randomized double-blind placebo-controlled trial.
    Esalatmanesh K; Loghman A; Esalatmanesh R; Soleimani Z; Khabbazi A; Mahdavi AM; Mousavi SGA
    Clin Rheumatol; 2021 Sep; 40(9):3591-3597. PubMed ID: 33674988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
    Koufany M; Jouzeau JY; Moulin D
    Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
    Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J
    J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia.
    Campia U; Matuskey LA; Tesauro M; Cardillo C; Panza JA
    Atherosclerosis; 2014 Jun; 234(2):436-40. PubMed ID: 24769306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.